Plasma advanced glycation end-products and skin autofluorescence are increased in COPD

European Respiratory Journal

Volumn 43, Issue 2, 2014, Pages 430-438

  Gopal, Poornima ^a   Reynaert, Niki L ^a   Scheijen, Jean L J M ^a   Engelen, Lean ^a   Schalkwijk, Casper G ^a   Franssen, Frits M E ^b   Wouters, Emiel F M ^a,b   Rutten, Erica P A ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Centre of Expertise for Chronic Organ Failure (CIRO)   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARGININE; CASE-CONTROL STUDIES; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; LUNG; LYSINE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SKIN; SMOKING; SPIROMETRY;

EID: 84893474731     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00135312     Document Type: Article

References (44)

1. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
2. Singh R, Barden A, Mori T, et al. Advanced glycation end-products: a review. Diabetologia 2001; 44: 129-146.
3. Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int Suppl 2007; 106: S17-S26.
4. Kokkola R, Andersson A, Mullins G, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005; 61: 1-9.
5. Sparvero LJ, Asafu-Adjei D, Kang R, et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 2009; 7: 17.
6. Bierhaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998; 37: 586-600.
7. Monnier VM. Nonenzymatic glycosylation, theMaillard reaction and the aging process. J Gerontol 1990; 45: B105-B111.
8. Monnier VM, Kohn RR, Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 1984; 81: 583-587.
9. Ahmed MU, Brinkmann Frye E, Degenhardt TP, et al. N-e-(carboxyethyl) lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997; 324: 565-570.
10. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993; 91: 2463-2469.
11. Mulder DJ, Water TV, Lutgers HL, et al. Skin autofluorescence, a novel marker for glycemic and oxidative stressderived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006; 8: 523-535.
12. Koetsier M, Lutgers HL, de Jonge C, et al. Reference values of skin autofluorescence. Diabetes Technol Ther 2010; 12: 399-403.
13. Januszewski AS, Sachithanandan N, Karschimkus C, et al. Non-invasive measures of tissue autofluorescence are increased in type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabet Med 2012; 29: 726-733.
14. Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007; 30: 107-112.
15. Kanazawa H, Kodama T, Asai K, et al. Increased levels of Ne-(carboxymethyl)lysine in epithelial lining fluid from peripheral airways in patients with chronic obstructive pulmonary disease: a pilot study. Clin Sci (Lond) 2010; 119: 143-149.
16. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
17. Teerlink T, Barto R, Ten Brink HJ, et al. Measurement of Ne-(carboxymethyl)lysine and Ne-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry. Clin Chem 2004; 50: 1222-1228.
18. Scheijen JL, van de Waarenburg MP, Stehouwer CD, et al. Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 610-614.
19. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
21. Mulder DJ, Water TV, Lutgers HL, et al. Skin autofluorescence, a novel marker for glycemic and oxidative stressderived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006; 8: 523-535.
22. Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47: 1324-1330.
23. Nordlund JJ, Ackles AE, Lerner AB. The effects of ultraviolet light and certain drugs on La-bearing Langerhans cells in murine epidermis. Cell Immunol 1981; 60: 50-63.
24. Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999; 344: 109-116.
25. Ispolnov K, Gomes RA, Silva MS, et al. Extracellular methylglyoxal toxicity in Saccharomyces cerevisiae: role of glucose and phosphate ions. J Appl Microbiol 2008; 104: 1092-1102.
26. Gopal P, Rutten EP, Dentener MA, et al. Decreased plasma sRAGE levels in COPD: influence of oxygen therapy. Eur J Clin Invest 2012; 42: 807-814.
27. Miniati M, Monti S, Basta G, et al. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res 2011; 12: 37.
28. Baynes JW, Thorpe SR. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000; 28: 1708-1716.
29. Thornalley PJ, Jahan I, Ng R. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem 2001; 129: 543-549.
30. Dyer DG, Blackledge JA, Thorpe SR, et al. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 1991; 266: 11654-11660.
31. Fu MX, Requena JR, Jenkins AJ, et al. The advanced glycation end product, Ne-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996; 271: 9982-9986.
32. Miyata T, Inagi R, Asahi K, et al. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FEBS Lett 1998; 437: 24-28.
33. Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochem J 1987; 245: 243-250.
34. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
35. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
36. Yamagishi S. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications. Ther Apher Dial 2009; 13: 534-539.
37. Agustí A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012; 7: e37483.
38. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004; 95: 233-238.
39. Yamagishi S, Nakamura K, Inoue H, et al. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients. Med Hypotheses 2005; 64: 1208-1210.
40. Nin JW, Jorsal A, Ferreira I, et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care 2011; 34: 442-447.
41. Baidoshvili A, Krijnen PA, Kupreishvili K, et al. Ne-(carboxymethyl) lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction? Arterioscler Thromb Vasc Biol 2006; 26: 2497-2503.
42. Lutgers HL, Graaff R, Links TP, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006; 29: 2654-2659.
43. Noordzij MJ, Lefrandt JD, Graaff R, et al. Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther 2011; 13: 165-170.
44. Meerwaldt R, Hartog JW, Graaff R, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 3687-3693.